Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervix Carcinoma Recurrent”

326 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 326 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableLooking for participantsNCT07493928
What this trial is testing

HPV After chemoRadioTherapy

Who this might be right for
Cervical Cancer RecurrentRadiotherapyCell Free DNA+1 more
General University Hospital, Prague 120
Testing effectiveness (Phase 2)Study completedNCT01229930
What this trial is testing

Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery

Who this might be right for
Cervical Cancer
University of Glasgow 130
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Early research (Phase 1)Looking for participantsNCT07081984
What this trial is testing

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors

Who this might be right for
HPV 16+ Recurrent or Metastatic CancerHNSCCCervical Cancer
Therorna 12
Large-scale testing (Phase 3)Looking for participantsNCT06459687
What this trial is testing

Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Lee's Pharmaceutical Limited 440
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Not applicableNot Yet RecruitingNCT06150222
What this trial is testing

Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study

Who this might be right for
Cancer, CervicalRecurrenceMetastasis
Erasmus Medical Center 350
Not applicableStudy completedNCT01160185
What this trial is testing

Meta-analysis of Efficacy of Topotecan

Who this might be right for
Cervical Intraepithelial Neoplasia
GlaxoSmithKline 1
Early research (Phase 1)WithdrawnNCT00118300
What this trial is testing

Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05557565
What this trial is testing

A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Qilu Pharmaceutical Co., Ltd. 150
Not applicableLooking for participantsNCT06644846
What this trial is testing

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Who this might be right for
Cervical CancerGynecologic CancerRecurrent Cancer
Tata Memorial Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01676818
What this trial is testing

Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CancerStage IIIA Cervical CancerStage IIIB Cervical Cancer+2 more
University of Southern California 32
Testing effectiveness (Phase 2)Study completedNCT00548418
What this trial is testing

Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
Washington University School of Medicine 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07172217
What this trial is testing

The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC

Who this might be right for
Recurrent Cervical Cancer
Qilu Hospital of Shandong University 33
Early research (Phase 1)Ended earlyNCT03277482
What this trial is testing

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

Who this might be right for
Recurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more
Dana-Farber Cancer Institute 16
Testing effectiveness (Phase 2)Looking for participantsNCT07051486
What this trial is testing

A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd. 60
Large-scale testing (Phase 3)UnknownNCT05446883
What this trial is testing

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
METASTATIC CERVICAL CANCER
Qilu Pharmaceutical Co., Ltd. 498
Testing effectiveness (Phase 2)Looking for participantsNCT05512208
What this trial is testing

Avutometinib (VS-6766) Plus Defactinib

Who this might be right for
Endometrioid CancerMucinous Ovarian CancerHigh Grade Serous Ovarian Cancer+2 more
University of Oklahoma 55
Testing effectiveness (Phase 2)UnknownNCT04974944
What this trial is testing

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Who this might be right for
Stage IVB Cervical CancerRecurrent Cervical CancerPersistent Cervical Cancer
Sun Yat-sen University 172
Load More Results